| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 0.1 |